The Celobar IH1_N_S_AH0_D_AH0_N_T W_AA1_Z AH0 F_AA2_R_M_AH0_S_UW1_T_IH0_K_AH0_L F_R_AO1_D DH_AE1_T AH0_K_ER1_D IH0_N Brazil IH0_N 2003    AH0_N_D R_IH0_Z_AH1_L_T_IH0_D IH0_N DH_AH0 D_EH1_TH AH1_V M_AO1_R DH_AE1_N T_W_EH1_N_T_IY0     R_EY1 P_EY1_SH_AH0_N_T_S B_AY1 B_EH1_R_IY0_AH0_M P_OY1_Z_AH0_N_IH0_NG     Laborat R_IY1_OW0 Enila W_AA1_Z AH0 S_M_AO1_L Brazilian pharmaceutics M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_ER0 HH_UW1 M_EY1_D AE1_N AO1_R_AH0_L R_EY1 K_AA1_N_T_R_AE0_S_T M_IY1_D_IY0_AH0_M T_R_EY1_D_M_AA2_R_K_T Celobar The M_IY1_D_IY0_AH0_M EH1_S M_EY1_N IH2_N_G_R_IY1_D_IY0_AH0_N_T W_AA1_Z pharmaceutics G_R_EY1_D B_EH1_R_IY0_AH0_M S_AH1_L_F_EY2_T    BaSO4    IH2_M_P_AO1_R_T_IH0_D F_R_AH1_M Germany In 2003    W_IH0_TH_AW1_T HH_AE1_V_IH0_NG DH_AH0 N_EH1_S_AH0_S_EH2_R_IY0 EH2_K_S_P_ER0_T_IY1_Z AO1_R AO2_TH_ER0_AH0_Z_EY1_SH_AH0_N    DH_EY1 T_R_AY1_D T_UW1 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0 BaSO4 IH0_N HH_AW1_S F_R_AH1_M M_AH1_CH CH_IY1_P_ER0 T_EH1_K_N_IH0_K_AH0_L G_R_EY1_D B_EH1_R_IY0_AH0_M K_AA1_R_B_AH0_N_EY2_T    BaCO3 Non R_IY0_AE1_K_T_AH0_D K_AA1_R_B_AH0_N_EY2_T AH0_N_D AH1_DH_ER0 B_EH1_R_IY0_AH0_M S_AO1_L_T_S DH_AE1_T R_IH0_M_EY1_N_D IH0_N DH_AH0 AH0_D_AH1_L_T_ER0_EY2_T_IH0_D P_R_AA1_D_AH0_K_T K_IH1_L_D N_AY1_N P_EY1_SH_AH0_N_T_S The F_ER1_S_T D_EH1_TH W_AA1_Z Ricardo Diomedes    HH_UW1 HH_AE1_D T_EY1_K_AH0_N Celobar AA1_N May 21    2003 AE1_T AH0 K_L_IH1_N_IH0_K IH0_N Nova Igua Y_UW1 N_IH1_R Rio D_IY1 Janeiro F_Y_UW1 AW1_ER0_Z L_EY1_T_ER0 HH_IY1 W_AA1_Z S_AH1_F_ER0_IH0_NG F_R_AH1_M V_AA1_M_AH0_T_IH0_NG    D_AY2_ER0_IY1_AH0    AE0_B_D_AA1_M_AH0_N_AH0_L P_EY1_N_Z    AH0_N_D W_IY1_K_N_AH0_S ;  HH_IY1 D_AY1_D DH_AH0 N_EH1_K_S_T D_EY1 IH0_N Nil P_OW1_L_AH0_S Postmortem IH0_G_Z_AE1_M_Z K_AH0_N_F_ER1_M_D DH_AE1_T B_EH1_R_IY0_AH0_M P_OY1_Z_AH0_N_IH0_NG W_AA1_Z DH_AH0 K_AA1_Z AH1_V D_EH1_TH Analysis AH1_V DH_AH0 Celobar B_AY1 DH_AH0 Oswaldo Cruz Institute SH_OW1_D AH1_P T_UW1 14 %  unreacted K_AA1_R_B_AH0_N_EY2_T    DH_AH0 M_AE1_K_S_AH0_M_AH0_M AH0_L_AW1_D L_IH1_M_AH0_T B_IY1_IH0_NG 001 %     The AH1_DH_ER0 EY1_T D_EH1_TH_S AH0_K_ER1_D IH0_N DH_AH0 S_T_EY1_T AH1_V Goi EH1_S    W_EH1_R M_OW1_S_T AH1_V DH_AH0 K_AH0_N_T_AE1_M_AH0_N_EY2_T_AH0_D L_AA1_T HH_AE1_D B_IH1_N SH_IH1_P_T    Coincidentally DH_AH0 S_EY1_M S_T_EY1_T AE1_Z DH_AH0 Goi nia AE1_K_S_AH0_D_AH0_N_T    Authorities W_ER1 W_AO1_R_N_D AE1_F_T_ER0 DH_AH0 F_ER1_S_T D_EH1_TH_S    R_IH0_K_AO1_L_D DH_AH0 L_AA1_T    AH0_N_D K_L_OW1_Z_D DH_AH0 L_AE1_B_R_AH0_T_AO2_R_IY0    W_IH1_CH IH0_V_EH1_N_CH_AH0_W_AH0_L_IY0 W_EH1_N_T B_AE1_NG_K_R_AH0_P_T On January 29    2009    Enila EH1_S CEO    rcio Icahahy M_AA1_R_AH0 Lima     AH0_N_D DH_AH0 K_EH1_M_IH0_S_T HH_UW1 K_AE1_R_IY0_D AW1_T DH_AH0 S_IH1_N_TH_AH0_S_AH0_S    Ant nio Carlos Fonseca D_AA1 Silva    W_ER1 S_EH1_N_T_AH0_N_S_T T_UW1 20 AH0_N_D 22 Y_IH1_R_Z IH0_N JH_EY1_L    R_IH0_S_P_EH1_K_T_IH0_V_L_IY0    